| Trends in underlying causes of death in people with HIV from 1999 to 2011 (D: A: D): a multicohort collaboration CJ Smith, L Ryom, R Weber, P Morlat, C Pradier, P Reiss, JD Kowalska, ... The Lancet 384 (9939), 241-248, 2014 | 1165 | 2014 |
| Association Between Antiretroviral Exposure and Renal Impairment Among HIV-Positive Persons With Normal Baseline Renal Function: the D:A:D Studya L Ryom, A Mocroft, O Kirk, SW Worm, DA Kamara, P Reiss, M Ross, ... The Journal of infectious diseases 207 (9), 1359-1369, 2013 | 377 | 2013 |
| An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D: A: D) study N Friis-Møller, L Ryom, C Smith, R Weber, P Reiss, F Dabis, S De Wit, ... European journal of preventive cardiology 23 (2), 214-223, 2016 | 263 | 2016 |
| Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CR Swanepoel, MG Atta, VD D’Agati, MM Estrella, AB Fogo, S Naicker, ... Kidney international 93 (3), 545-559, 2018 | 255 | 2018 |
| Cardiovascular disease and use of contemporary protease inhibitors: the D: A: D international prospective multicohort study L Ryom, JD Lundgren, W El-Sadr, P Reiss, O Kirk, M Law, A Phillips, ... The lancet HIV 5 (6), e291-e300, 2018 | 229 | 2018 |
| Cumulative and current exposure to potentially nephrotoxic antiretrovirals and development of chronic kidney disease in HIV-positive individuals with a normal baseline … A Mocroft, JD Lundgren, M Ross, CA Fux, P Reiss, O Moranne, P Morlat, ... The lancet HIV 3 (1), e23-e32, 2016 | 210 | 2016 |
| Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D: A: D study AC Achhra, A Mocroft, P Reiss, C Sabin, L Ryom, S De Wit, CJ Smith, ... HIV medicine 17 (4), 255-268, 2016 | 178 | 2016 |
| 2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0 L Ryom, A Cotter, R De Miguel, C Béguelin, D Podlekareva, JR Arribas, ... HIV medicine 21 (10), 617-624, 2020 | 173 | 2020 |
| Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort A Pelchen-Matthews, L Ryom, ÁH Borges, S Edwards, C Duvivier, ... Aids 32 (16), 2405-2416, 2018 | 150 | 2018 |
| Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D: A: D study A Mocroft, JD Lundgren, M Ross, M Law, P Reiss, O Kirk, C Smith, ... PLoS medicine 12 (3), e1001809, 2015 | 144 | 2015 |
| Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration CA Sabin, P Reiss, L Ryom, AN Phillips, R Weber, M Law, E Fontas, ... BMC medicine 14, 1-14, 2016 | 142 | 2016 |
| Atazanavir is not associated with an increased risk of cardio or cerebrovascular disease events AA Monforte, P Reiss, L Ryom, W El-Sadr, F Dabis, S De Wit, SW Worm, ... Aids 27 (3), 407-415, 2013 | 137 | 2013 |
| Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons L Ryom, C Boesecke, V Gisler, C Manzardo, JK Rockstroh, M Puoti, ... HIV medicine 17 (2), 83-88, 2016 | 128 | 2016 |
| Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults A Mocroft, J Neuhaus, L Peters, L Ryom, M Bickel, D Grint, J Koirala, ... PloS one 7 (7), e40245, 2012 | 112 | 2012 |
| Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0 L Ryom, C Boesecke, M Bracchi, J Ambrosioni, A Pozniak, J Arribas, ... HIV medicine 19 (5), 309-315, 2018 | 106 | 2018 |
| Kidney failure related to broad-spectrum antibiotics in critically ill patients: secondary end point results from a 1200 patient randomised trial JUS Jensen, L Hein, B Lundgren, MH Bestle, T Mohr, MH Andersen, ... BMJ open 2 (2), e000635, 2012 | 104 | 2012 |
| Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons L Ryom, A Mocroft, O Kirk, M Ross, P Reiss, CA Fux, P Morlat, O Moranne, ... Aids 28 (2), 187-199, 2014 | 103 | 2014 |
| Associations between integrase strand-transfer inhibitors and cardiovascular disease in people living with HIV: a multicentre prospective study from the RESPOND cohort consortium B Neesgaard, L Greenberg, JM Miró, K Grabmeier-Pfistershammer, ... The lancet HIV 9 (7), e474-e485, 2022 | 94 | 2022 |
| Major revision version 11.0 of the European AIDS clinical society guidelines 2021 L Ryom, R De Miguel, AG Cotter, D Podlekareva, C Beguelin, ... HIV medicine 23 (8), 849-858, 2022 | 88 | 2022 |
| Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive persons L Ryom, JD Lundgren, S De Wit, H Kovari, P Reiss, M Law, W El-Sadr, ... Aids 30 (11), 1731-1743, 2016 | 77 | 2016 |